Ulusan, M.; Erdogan, M.A.; Simsek, O.; Dogan, Z.; Ciftci, B.B.; Atalan, G.; Erbas, O.
Baricitinib Mitigates Methotrexate-Induced Liver Fibrosis Model via YAP Pathway. Medicina 2025, 61, 857.
https://doi.org/10.3390/medicina61050857
AMA Style
Ulusan M, Erdogan MA, Simsek O, Dogan Z, Ciftci BB, Atalan G, Erbas O.
Baricitinib Mitigates Methotrexate-Induced Liver Fibrosis Model via YAP Pathway. Medicina. 2025; 61(5):857.
https://doi.org/10.3390/medicina61050857
Chicago/Turabian Style
Ulusan, Mehmet, Mumin Alper Erdogan, Ozkan Simsek, Zafer Dogan, Bertug Bekir Ciftci, Gultekin Atalan, and Oytun Erbas.
2025. "Baricitinib Mitigates Methotrexate-Induced Liver Fibrosis Model via YAP Pathway" Medicina 61, no. 5: 857.
https://doi.org/10.3390/medicina61050857
APA Style
Ulusan, M., Erdogan, M. A., Simsek, O., Dogan, Z., Ciftci, B. B., Atalan, G., & Erbas, O.
(2025). Baricitinib Mitigates Methotrexate-Induced Liver Fibrosis Model via YAP Pathway. Medicina, 61(5), 857.
https://doi.org/10.3390/medicina61050857